| 1. |
?Kim YW, Kim IY.The role of surgery for asymptomatic primary tumors in unresectable stageⅣcolorectal cancer[J].Ann Coloproctol, 2013, 29(2):44-54.
|
| 2. |
Temple LK, Hsieh L, Wong WD, et al.Use of surgery among elderly patients with stageⅣcolorectal cancer[J].J Clin Oncol, 2004, 22(17):3475-3484.
|
| 3. |
Cook AD, Single R, McCahill LE.Surgical resection of primary tumors in patients who present with stageⅣcolorectal cancer:an analysis of surveillance, epidemiology, and end results data, 1988 to 2000[J].Ann Surg Oncol, 2005, 12(8):637-645.
|
| 4. |
Tebbutt NC, Norman AR, Cunningham D, et al.Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases[J].Gut, 2003, 52(4):568-573.
|
| 5. |
Konyalian VR, Rosing DK, Haukoos JS, et al.The role of primary tumour resection in patients with stageⅣcolorectal cancer[J].Colorectal Dis, 2007, 9(5):430-437.
|
| 6. |
Stillwell AP, Buettner PG, Ho YH.Meta-analysis of survival of patients with stageⅣcolorectal cancer managed with surgical resection versus chemotherapy alone[J].World J Surg, 2010, 34(4):797-807.
|
| 7. |
Ruo L, Gougoutas C, Paty PB, et al.Elective bowel resection for incurable stageⅣcolorectal cancer:prognostic variables for asymptomatic patients[J].J Am Coll Surg, 2003, 196(5):722-728.
|
| 8. |
Anwar S, Peter MB, Dent J, et al.Palliative excisional surgery for primary colorectal cancer in patients with incurable metastatic disease.Is there a survival benefit? A systematic review[J].Colorectal Dis, 2012, 14(8):920-930.
|
| 9. |
Stillwell AP, Ho YH, Veitch C.Systematic review of prognostic factors related to overall survival in patients with stageⅣcolorectal cancer and unresectable metastases[J].World J Surg, 2011, 35(3):684-692.
|
| 10. |
Tekkis PP, Kinsman R, Thompson MR, et al.The association of coloproctology of Great Britain and Ireland study of large bowel obstruction caused by colorectal cancer[J].Ann Surg, 2004, 240(1):76-81.
|
| 11. |
Winner M, Mooney SJ, Hershman DL, et al.Management and outcomes of bowel obstruction in patients with stageⅣcolon cancer:a population-based cohort study[J].Dis Colon Rectum, 2013, 56(7):834-843.
|
| 12. |
Scoggins CR, Meszoely IM, Blanke CD, et al.Nonoperative management of primary colorectal cancer in patients with stageⅣdisease[J].Ann Surg Oncol, 1999, 6(7):651-657.
|
| 13. |
Chau I, Cunningham D.Adjuvant therapy in colon cancer-what, when and how?[J].Ann Oncol, 2006, 17(9):1347-1359.
|
| 14. |
Carpizo DR, D'Angelica M.Liver resection for metastatic colorectal cancer in the presence of extrahepatic disease[J].Lancet Oncol, 2009, 10(8):801-809.
|
| 15. |
Muratore A, Zorzi D, Bouzari H, et al.Asymptomatic colorectal cancer with un-resectable liver metastases:immediate colorectal resection or up-front systemic chemotherapy?[J].Ann Surg Oncol, 2007, 14(2):766-770.
|
| 16. |
Michel P, Roque I, Di Fiore F, et al.Colorectal cancer with nonresectable synchronous metastases:should the primary tumor be resected?[J].Gastroenterol Clin Biol, 2004, 28(5):434-437.
|
| 17. |
Winner M, Mooney SJ, Hershman DL, et al.Incidence and predictors of bowel obstruction in elderly patients with stageⅣcolon cancer:a population-based cohort study[J].JAMA Surg, 2013, 148(8):715-722.
|
| 18. |
Nitzkorski JR, Farma JM, Watson JC, et al.Outcome and natural history of patients with stageⅣcolorectal cancer receiving chemotherapy without primary tumor resection[J].Ann Surg Oncol, 2012, 19(2):379-383.
|
| 19. |
Labianca R, Nordlinger B, Beretta GD, et al; ESMO Guidelines Working Group.Early colon cancer:ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J].Ann Oncol, 2013, 24 Suppl 6:vi64vi72.
|
| 20. |
Seo GJ, Park JW, Yoo SB, et al.Intestinal complications after palliative treatment for asymptomatic patients with unresectable stageⅣcolorectal cancer[J].J Surg Oncol, 2010, 102(1):94-99.
|
| 21. |
Ballian N, Mahvi DM, Kennedy GD.Colonoscopic findings and tumor site do not predict bowel obstruction during medical treatment of stageⅣcolorectal cancer[J].Oncologist, 2009, 14(6):580-585.
|
| 22. |
Matsumoto T, Hasegawa S, Matsumoto S, et al.Overcoming the challenges of primary tumor management in patients with metastatic colorectal cancer unresectable for cure and an asymptomatic primary tumor[J].Dis Colon Rectum, 2014, 57(6):679-686.
|
| 23. |
Verhoef C, de Wilt JH, Burger JW, et al.Surgery of the primary in stageⅣcolorectal cancer with unresectable metastases[J].Eur J Cancer, 2011, 47(Suppl 3):S61-S66.
|
| 24. |
Poultsides GA, Servais EL, Saltz LB, et al.Outcome of primary tumor in patients with synchronous stageⅣcolorectal cancer receiving combination chemotherapy without surgery as initial treatment[J].J Clin Oncol, 2009, 27(20):3379-3384.
|
| 25. |
Cirocchi R, Trastulli S, Abraha I, et al.Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stageⅣcolorectal cancer[J].Cochrane Database Syst Rev, 2012, 8:CD008997.
|
| 26. |
Yun JA, Huh JW, Park YA, et al.The role of palliative resection for asymptomatic primary tumor in patients with unresectable stageⅣcolorectal cancer[J].Dis Colon Rectum, 2014, 57(9):1049-1058.
|
| 27. |
Scheer MG, Sloots CE, van der Wilt GJ, et al.Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases[J].Ann Oncol, 2008, 19(11):1829-1835.
|
| 28. |
Damjanov N, Weiss J, Haller DG.Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease[J].Oncologist, 2009, 14(10):963-969.
|
| 29. |
Venook AP, Niedzwiecki D, Lenz HJ, et al.CALGB/SWOG 80405:PhaseⅢtrial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC)[J].J Clin Oncol, 2014, 32(suppl; abstr LBA3):5s.
|
1/5
WeChat